Given the roles of mutated pyrin protein in regulating caspase-1 and IL-1ß activation in inflammasome pathway, recent studies have demonstrated successful use of anti-IL1 therapies for the treatment of FMF (21, 25, 39, 40). Here, IL1A is linked to familial Mediterranean fever.